Two-year clinical results from a study of BioPoly’s RS Partial Resurfacing Knee indicate statistically significant and clinically meaningful improvement in knee pain and function.
Compared to microfracture, the 2-year data indicates significantly improved patient outcomes, especially in quality of life and sports measures. Notably, positive outcomes were not age-dependent.
This study data was reported in the Journal of Bone and Joint Surgery. Longer-term clinical data is being collected for the cohort of patients in this study, and 5-year results will be published.
BioPoly® material behaves like a synthetic, self-lubricating cartilage which may be used to replace only the damaged portion of joints vs. total joint repair. the resurfacing knee and a partial resurfacing shoulder are CE Marked and available in Europe.
Two-year clinical results from a study of BioPoly's RS Partial Resurfacing Knee indicate statistically significant and clinically meaningful improvement in knee pain and function.
Compared to microfracture, the 2-year data indicates significantly improved patient outcomes, especially in quality of life and sports measures. Notably, positive...
Two-year clinical results from a study of BioPoly’s RS Partial Resurfacing Knee indicate statistically significant and clinically meaningful improvement in knee pain and function.
Compared to microfracture, the 2-year data indicates significantly improved patient outcomes, especially in quality of life and sports measures. Notably, positive outcomes were not age-dependent.
This study data was reported in the Journal of Bone and Joint Surgery. Longer-term clinical data is being collected for the cohort of patients in this study, and 5-year results will be published.
BioPoly® material behaves like a synthetic, self-lubricating cartilage which may be used to replace only the damaged portion of joints vs. total joint repair. the resurfacing knee and a partial resurfacing shoulder are CE Marked and available in Europe.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
